These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 28866897

  • 1. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT.
    Prins FM, van der Velden JM, Gerlich AS, Kotte ANTJ, Eppinga WSC, Kasperts N, Verlaan JJ, Pameijer FA, Kerkmeijer LGW.
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S147-S154. PubMed ID: 28866897
    [Abstract] [Full Text] [Related]

  • 2. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
    Gerlich AS, van der Velden JM, Kotte ANTJ, Tseng CL, Fanetti G, Eppinga WSC, Kasperts N, Intven MPW, Pameijer FA, Philippens MEP, Verkooijen HM, Seravalli E.
    Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
    [Abstract] [Full Text] [Related]

  • 3. Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy.
    Raman S, Chin L, Erler D, Atenafu EG, Cheung P, Chu W, Chung H, Loblaw A, Poon I, Rubenstein J, Soliman H, Sahgal A, Tseng CL.
    Int J Radiat Oncol Biol Phys; 2018 Nov 15; 102(4):735-743.e1. PubMed ID: 29748100
    [Abstract] [Full Text] [Related]

  • 4. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
    Redmond KJ, Lo SS, Soltys SG, Yamada Y, Barani IJ, Brown PD, Chang EL, Gerszten PC, Chao ST, Amdur RJ, De Salles AA, Guckenberger M, Teh BS, Sheehan J, Kersh CR, Fehlings MG, Sohn MJ, Chang UK, Ryu S, Gibbs IC, Sahgal A.
    J Neurosurg Spine; 2017 Mar 15; 26(3):299-306. PubMed ID: 27834628
    [Abstract] [Full Text] [Related]

  • 5. Interobserver variability in gross tumor volume contouring in non-spine bone metastases.
    de la Pinta C, LaTorre RG, Martínez-Lorca A, Fernández E, Hernanz R, Martín M, Domínguez JA, Muñóz T, Canales E, Vallejo C, Alarza M, Hervás A, Garví M, Pino V, Sancho S.
    J Clin Transl Res; 2022 Dec 29; 8(6):465-469. PubMed ID: 36452000
    [Abstract] [Full Text] [Related]

  • 6. Volumetric and dosimetric impact of MRI in delineation of gross tumor volume of non-spinal vertebral metastases treated with stereotactic ablative radiation therapy.
    Ilamurugu A, Chandrasekaran A, Ayyalusamy A, Prasanna Satpathy S, Reddy JM, Arora S, Subramanian S, Velayudham R.
    Cancer Radiother; 2021 Apr 29; 25(2):135-140. PubMed ID: 33422419
    [Abstract] [Full Text] [Related]

  • 7. Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system.
    Giaj-Levra N, Figlia V, Cuccia F, Mazzola R, Nicosia L, Ricchetti F, Rigo M, Attinà G, Vitale C, Sicignano G, De Simone A, Naccarato S, Ruggieri R, Alongi F.
    Radiat Oncol; 2021 Oct 09; 16(1):197. PubMed ID: 34627313
    [Abstract] [Full Text] [Related]

  • 8. Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.
    Chapman ER, Nicholls L, Suh YE, Khoo V, Levine D, Ap Dafydd D, Van As N.
    Radiother Oncol; 2023 Mar 09; 180():109461. PubMed ID: 36634852
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN, Reichardt W, Bishop AJ, Suki D, Rhines LD, Settle SH, Brown PD, Li J, Rao G, Chang EL, Tatsui CE.
    J Neurosurg Spine; 2015 Jan 09; 22(1):52-9. PubMed ID: 25360530
    [Abstract] [Full Text] [Related]

  • 10. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
    Ghia AJ, Chang EL, Bishop AJ, Pan HY, Boehling NS, Amini B, Allen PK, Li J, Rhines LD, Tannir NM, Tatsui CE, Brown PD, Yang JN.
    J Neurosurg Spine; 2016 May 09; 24(5):829-36. PubMed ID: 26799117
    [Abstract] [Full Text] [Related]

  • 11. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
    Yamada Y, Katsoulakis E, Laufer I, Lovelock M, Barzilai O, McLaughlin LA, Zhang Z, Schmitt AM, Higginson DS, Lis E, Zelefsky MJ, Mechalakos J, Bilsky MH.
    Neurosurg Focus; 2017 Jan 09; 42(1):E6. PubMed ID: 28041329
    [Abstract] [Full Text] [Related]

  • 12. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
    Giaj-Levra N, Niyazi M, Figlia V, Napoli G, Mazzola R, Nicosia L, Corradini S, Ruggieri R, Minniti G, Alongi F.
    Radiat Oncol; 2019 Oct 26; 14(1):184. PubMed ID: 31655620
    [Abstract] [Full Text] [Related]

  • 13. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS, Fahim DK, Gerszten PC, Flickinger JC, Sahgal A, Grills IS, Sheehan J, Kersh R, Shin J, Oh K, Mantel F, Guckenberger M, , on behalf of the Elekta Spine Radiosurgery Research Consortium.
    J Neurosurg Spine; 2016 Jun 26; 24(6):928-36. PubMed ID: 26895526
    [Abstract] [Full Text] [Related]

  • 14. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
    Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD.
    Pract Radiat Oncol; 2015 Jun 26; 5(6):e589-e596. PubMed ID: 26142027
    [Abstract] [Full Text] [Related]

  • 15. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e439-45. PubMed ID: 21641122
    [Abstract] [Full Text] [Related]

  • 16. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I, Al-Omair A, Masucci GL, Masson-Côté L, Lochray F, Korol R, Cheng L, Xu W, Yee A, Fehlings MG, Bjarnason GA, Sahgal A.
    J Neurosurg Spine; 2014 Nov 15; 21(5):711-8. PubMed ID: 25170656
    [Abstract] [Full Text] [Related]

  • 17. The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions.
    Badakhshi H, Graf R, Prasad V, Budach V.
    Cancer Imaging; 2014 Jun 25; 14(1):25. PubMed ID: 25608761
    [Abstract] [Full Text] [Related]

  • 18. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery.
    Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, Sheehan J, Gerszten PC, Chang E, Gibbs I, Soltys S, Sahgal A, Deasy J, Flickinger J, Quader M, Mindea S, Yamada Y.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):e597-605. PubMed ID: 22608954
    [Abstract] [Full Text] [Related]

  • 19. MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy.
    den Hartogh MD, Philippens ME, van Dam IE, Kleynen CE, Tersteeg RJ, Pijnappel RM, Kotte AN, Verkooijen HM, van den Bosch MA, van Vulpen M, van Asselen B, van den Bongard HD.
    Radiat Oncol; 2014 Feb 26; 9():63. PubMed ID: 24571783
    [Abstract] [Full Text] [Related]

  • 20. [Value of integrated positron-emission tomography and computed tomography in gross tumor volume delineation for radiotherapy for bone metastasis].
    Zhu XX, Chen YQ, Chen LH.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun 26; 24(6):700-2, 705. PubMed ID: 15201095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.